Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells
Authors
Keywords
Interleukin 19, Osteoclast differentiation, NF-κB, p38MAPK, c-Fos
Journal
CYTOKINE
Volume 144, Issue -, Pages 155591
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.cyto.2021.155591
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevated Expression of Cathepsin K in Periodontal Ligament Fibroblast by Inflammatory Cytokines Accelerates Osteoclastogenesis via Paracrine Mechanism in Periodontal Disease
- (2021) Soon Chul Heo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms involved in normal and pathological osteoclastogenesis
- (2018) Kyung-Hyun Park-Min CELLULAR AND MOLECULAR LIFE SCIENCES
- Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1
- (2018) Qiuyue Peng et al. CYTOKINE
- The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis
- (2018) Tue W. Kragstrup et al. Frontiers in Immunology
- Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction
- (2018) Weishuai An et al. BRITISH JOURNAL OF PHARMACOLOGY
- Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation
- (2018) Kai Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis
- (2016) Yasuyuki Fujimoto et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity
- (2015) T. W. Kragstrup et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Interleukin 19 reduces inflammation in chemically induced experimental colitis
- (2015) Yukiko Matsuo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Interleukin-19 Acts as a Negative Autocrine Regulator of Activated Microglia
- (2015) Hiroshi Horiuchi et al. PLoS One
- IL-19 as a Potential Therapeutic in Autoimmune and Inflammatory Diseases
- (2011) Yasu-Taka Azuma et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-4 inhibits RANKL-induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis
- (2011) Jing Cheng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interleukin-19 blockade attenuates collagen-induced arthritis in rats
- (2011) Y.-H. Hsu et al. RHEUMATOLOGY
- Biology of interleukin-10
- (2010) Robert Sabat et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathway
- (2010) Masanobu Tsubaki et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF- B Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
- (2009) K.-H. Park-Min et al. JOURNAL OF IMMUNOLOGY
- Expression and Suppressive Effects of Interleukin-19 on Vascular Smooth Muscle Cell Pathophysiology and Development of Intimal Hyperplasia
- (2008) Ying Tian et al. AMERICAN JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started